USDA approves parvo preventative for puppiesJune 27, 2025The conditional approval of the Canine Parvovirus Monoclonal Antibody (CPMA) for passive immunity allows veterinarians to protect exposed puppies from canine parvovirus.
SPONSORED CONTENTMore life to love for patients with certain types of canine CHF. See how different formulations help dog owners manage certain types of CHF in their pets. + Learn More
5 Questions With…Hunter Finn, DVM, veterinarian-influencerSeptember 3, 2024Dr. Finn shares about the cases he sees in his practice, how he integrates the first USDA-conditionally approved Canine Parvovirus Monoclonal Antibody (CPMA) treatment to handle parvo cases, and his social media work.
Monoclonal antibody (mAb) product innovation aim of facility expansion in KansasAugust 23, 2024A $130-million investment through 2026 is expected to bolster production and development of monoclonal antibody-based therapy, including a potential product in canine dermatology.
